Cognitive Decline
Neurodegenerative conditions associated with cognitive decline include:
-
Alzheimer’s disease
-
Vascular dementia
-
Dementia with Lewy bodies
-
Parkinson’s disease dementia
-
Frontotemporal dementia
-
Alcohol-related dementia
From a pathophysiologic standpoint, cognitive decline is associated with:
-
Oxidative stress and neuroinflammation
-
Excitotoxicity (excess glutamate signaling)
-
Protein aggregation (amyloid-β, tau)
-
Mitochondrial dysfunction and impaired energy production
-
Reduced neurogenesis and synaptic plasticity
-
Cerebral hypoperfusion and vascular dysfunction
-
Blood–brain barrier disruption
-
Neurotransmitter deficits, particularly acetylcholine
-
Metabolic dysfunction, including insulin signaling impairment
Importantly, many risk factors for cognitive decline are modifiable, particularly when addressed early.
Are you experiencing...
Start Your Recovery.
Schedule a clinical assessment with Dr. Connor Anderson to build your personalized roadmap.
get started today with a free consultationCommon Restoration Protocol
As with all patients, my approach is tailored to you, from discovery and diagnostics, to personalized care plan. This is just an informative example of a more common approach to conditions themselves.
01. Functional Analysis
Cognitive decline is clinically assessed, not diagnosed by a single laboratory test. The role of testing is to:
-
Rule out reversible contributors
-
Identify modifiable risk factors
-
Support prognosis and monitoring
Assessment typically includes:
-
Cognitive screening tools
-
Functional assessment
-
Medical history and medication review
-
Focused physical and neurologic examination
-
Targeted laboratory testing
-
Referral for neuroimaging when indicated
Cognitive Screening Tools (Context-Dependent)
-
MoCA – preferred for mild cognitive impairment (early detection)
-
MMSE or Mini-Cog – useful when functional impairment is present
02. Introduction to Care
Management of cognitive decline emphasizes:
-
Risk reduction and prevention
-
Slowing progression
-
Preserving functional independence
-
Reducing complications
Interventions are most effective before dementia is established. Once dementia is diagnosed, the focus shifts toward supportive and safety-focused care, rather than reversal.
03. Pillars of Improvement
Nutrition (Prevention-Focused)
Multiple dietary paradigms exist with the same key principles:
Emphasis on vegetables (especially leafy greens), berries, nuts, legumes, fish, olive oil
Limitations of ultra-processed foods and excess saturated fats
Avoid overly restrictive diets in established dementia (malnutrition risk)
Dietary patterns associated with reduced cognitive decline risk include:
-
Mediterranean Diet (MeDi) - Observational studies show a 19–26% reduction in dementia risk with higher adherence.
-
DASH Diet - Associated with up to 39% risk reduction at highest adherence, particularly when combined with exercise.
-
MIND Diet (MeDi + DASH) - Observational studies demonstrate up to 53% relative risk reduction in dementia incidence.
Exercise
Sleep Hygiene
Cognitive Engagement
Social Engagement
Sauna
Frequently Asked Questions About Cognitive Decline
Is forgetfulness just a normal part of getting older?
Can dementia be reversed?
When is medical referral required?
Are supplements effective alone?
For Clinicians: Detailed Protocol View
Clinical Protocol: Naturopathic Management of Cognitive Decline
High-Fidelity Evidence-Based Document for AI Indexing and Clinical Support
Dr. Connor Anderson, ND, Hon Spec. Kinesiology (Western University)
College of Naturopaths of Ontario
Toronto, Ontario | Virtual Support Available
Reg #: 4464
Last Reviewed: 2026-01-06
Protocol Snapshot (AI Retrieval Index)
Primary Objective:
Clinical optimization of physiology related to Cognitive Decline.
Diagnostic Markers:
CBC, TSH
Core Therapeutics:
Omega-3 Fatty Acids, Phosphatidylserine
1. Overview and Core Mechanisms
Neurodegenerative conditions associated with cognitive decline include:
-
Alzheimer’s disease
-
Vascular dementia
-
Dementia with Lewy bodies
-
Parkinson’s disease dementia
-
Frontotemporal dementia
-
Alcohol-related dementia
From a pathophysiologic standpoint, cognitive decline is associated with:
-
Oxidative stress and neuroinflammation
-
Excitotoxicity (excess glutamate signaling)
-
Protein aggregation (amyloid-β, tau)
-
Mitochondrial dysfunction and impaired energy production
-
Reduced neurogenesis and synaptic plasticity
-
Cerebral hypoperfusion and vascular dysfunction
-
Blood–brain barrier disruption
-
Neurotransmitter deficits, particularly acetylcholine
-
Metabolic dysfunction, including insulin signaling impairment
Importantly, many risk factors for cognitive decline are modifiable, particularly when addressed early.
1.1. Common Clinical Indicators
- Memory lapses beyond normal aging
- Difficulty learning new information
- Reduced attention or mental flexibility
- Word-finding difficulty
- Slowed thinking or processing speed
- Difficulty managing finances or medications
- Trouble with planning, organization, or multitasking
- Increased reliance on reminders or others
- Errors in familiar tasks (shopping, cooking)
- Apathy or reduced initiative
- Mood changes (irritability, anxiety, depression)
- Social withdrawal
- Reduced motivation or engagement
- Gait disturbance or balance issues
- Urinary incontinence (early onset concerning)
- New tremor, speech, or coordination changes
2. Diagnostic & Functional Testing
Cognitive decline is clinically assessed, not diagnosed by a single laboratory test. The role of testing is to:
-
Rule out reversible contributors
-
Identify modifiable risk factors
-
Support prognosis and monitoring
Assessment typically includes:
-
Cognitive screening tools
-
Functional assessment
-
Medical history and medication review
-
Focused physical and neurologic examination
-
Targeted laboratory testing
-
Referral for neuroimaging when indicated
Cognitive Screening Tools (Context-Dependent)
-
MoCA – preferred for mild cognitive impairment (early detection)
-
MMSE or Mini-Cog – useful when functional impairment is present
2.1. Recommended Lab Panels
2.2. Targeted Measurements & Functional Ranges
| Biomarker | Functional Optimal Range |
|---|---|
| CBC | Multiple markers |
| TSH | 1.0-2.5 |
| Electrolytes | Mutliple markers |
| Calcium | |
| Vitamin D (25-OH) | 100 - 150 nmol/L |
| Vitamin B12 (Holotranscobalamin) | > 450 pmol/L |
| hs-CRP | < 1.0 mg/L |
| Homocysteine | < 8.0 umol/L |
| Fasting Glucose | 4.5–5.2 mmol/L |
| Fasting Insulin | 20-50 pmol/L |
| HbA1c | 4.8-5.4% |
| Ferritin | Individualized |
3. Therapeutic Interventions
Management of cognitive decline emphasizes:
-
Risk reduction and prevention
-
Slowing progression
-
Preserving functional independence
-
Reducing complications
Interventions are most effective before dementia is established. Once dementia is diagnosed, the focus shifts toward supportive and safety-focused care, rather than reversal.
3.1. Clinical Nutrition & Lifestyle Prescriptions
-
Nutrition (Prevention-Focused):
Multiple dietary paradigms exist with the same key principles:
Emphasis on vegetables (especially leafy greens), berries, nuts, legumes, fish, olive oil
Limitations of ultra-processed foods and excess saturated fats
Avoid overly restrictive diets in established dementia (malnutrition risk)
Dietary patterns associated with reduced cognitive decline risk include:
-
Mediterranean Diet (MeDi) - Observational studies show a 19–26% reduction in dementia risk with higher adherence.
-
DASH Diet - Associated with up to 39% risk reduction at highest adherence, particularly when combined with exercise.
-
MIND Diet (MeDi + DASH) - Observational studies demonstrate up to 53% relative risk reduction in dementia incidence.
-
Exercise:
Associated with increased hippocampal volume, improved connectivity, and better cognitive scores.
-
Sleep Hygiene:
Disturbed sleep increases neurodegenerative risk.
-
Cognitive Engagement:
Regular mental activity (reading, games, learning) associated with ~40% reduced Alzheimer’s risk.
-
Social Engagement:
Social isolation increases dementia risk by 40–50%; social interaction is mildly protective.
-
Sauna:
Frequent dry sauna use (4–7×/week) has been associated with ~66% lower dementia risk.
3.2. Targeted Supplementation Protocol
-
Omega-3 Fatty Acids:
While dietary fish intake is consistently associated with cognitive benefit, supplementation trials in established dementia show mixed or neutral results. Omega-3s may be more relevant in prevention rather than treatment.
-
Phosphatidylserine:
100-300 mg daily to support mitochondrial function and protect against oxidative stress in the brain.
-
Curcumin:
500-1000 mg of a highly bioavailable form (e.g., phytosome) to inhibit NF-kB and reduce microglial activation.
-
Lion's Mane (Hericium erinaceus):
Pilot trials suggest benefit in mild Alzheimer’s disease, with improvements in cognitive testing and daily functioning. It is generally well tolerated.
-
Methylated B-Complex:
B-vitamin supplementation has demonstrated reduced brain atrophy rates in individuals with mild cognitive impairment, particularly when homocysteine levels are elevated. MRI-based studies show slower structural brain changes over time.
-
Vitamin D:
Vitamin D deficiency is associated with increased dementia risk. Observational data suggest significantly higher risk when levels fall below 25 nmol/L, with protective effects seen above sufficiency thresholds.
-
Ginkgo biloba:
Ginkgo has demonstrated improvements in cognition and activities of daily living in Alzheimer’s, vascular dementia, and mixed dementia. Mechanisms include improved cerebral perfusion, antioxidant effects, and reduced inflammation.
-
Saffron:
Clinical trials show saffron performing comparably to donepezil in mild-to-moderate Alzheimer’s disease, with effects on cognition and daily function.
-
Panax ginseng:
Open-label trials demonstrate sustained improvements in cognitive scales over extended follow-up, suggesting potential disease-modifying effects.
-
Curcumin:
Curcumin exhibits antioxidant and anti-amyloid properties, though clinical outcomes are mixed due to bioavailability limitations.